|
The device was used in treatment.One adelante sigma 6f introducer sheath and dilator were returned from the customer.There were no other accessories.No visible blood was found on the sheath or dilator.Upon removal of the dilator from the sheath, it was found that the green hub cap from the sheath remained attached to the dilator and a crack was observed on the hub cap.The presence (traces) of glue were found on the hub.The sheath tip was slightly damaged, the hemostatic valve and dilator tip looked normal.The cause of the issue is damaged/worn tooling (molding process).This lot was manufactured prior to the implementation of corrective action.The device history records were reviewed to confirm that the device passed all applicable in-process and final inspections.As per manufacturing procedure non-peelable sheath final assembly, the bonded caps are visually inspected after curing.A gap between bonded cap and hub should not exceed 0.020".Sheath should be free of damages and defects.Per qa procedure adelante sigma sheath in-process and final inspection: visual inspection, with naked eye, verify the assembled sheath is correct as per drawing.Ensure parts are free of loose or embedded foreign matter.Look for any damages such as flash, dents, melted/burnt material or excessive adhesive in cap and sideport joints.Verify the snap lock bonded cap is properly assembled and aligned on sheath hub.Gently pull on cap and rotate to ensure it is firmly attached to sheath hub.The adelante sigma introducer instructions for use (ifu) is provided with this product.It informs the user: device is supplied sterile.Do not use if package has been previously opened or damaged.Prior to use, read all package inserts, warnings, precautions, and instructions.Failure to do so may result in severe patient injury or death.Procedure must be performed by trained medical personnel well versed in anatomical landmarks, safe technique, and potential complications.The product is designed for single use only.Risks of reusing the product are: structural integrity might get compromised, biological tissue residue leaving pathogenic bacteria, viruses, and other microorganisms could re-infect a patient.Do not resterilize or reuse.Do not alter the device in any way.Based on this investigation, the returned device was confirmed to have a crack in the hub cap of the sheath.Corrective action was implemented for this issue and personnel were notified.The risk remains acceptable.The event will be re-evaluated if additional information becomes available.Oscor will continue to monitor this event type and risk.Oscor inc.Is submitting the above report to comply with 21 cfr part 803, the medical device reporting regulation.The report is based upon information obtained by oscor inc.Which the company may not have been able to investigate or verify prior to the date the report was required by fda.This report does not constitute an admission that the device, oscor inc., or its employees, caused or contributed to the event described in this report.Nor does this report reflect a conclusion by fda, oscor inc., or its employees, that the report constitutes an admission that the device, oscor inc., or its employees caused or contributed to the event described in this report.
|